Pietro Maria Ferrando

ORCID: 0000-0001-6011-3128
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Breast Implant and Reconstruction
  • Reconstructive Surgery and Microvascular Techniques
  • Breast Lesions and Carcinomas
  • Tissue Engineering and Regenerative Medicine
  • Body Contouring and Surgery
  • Surgical Sutures and Adhesives
  • Surgical site infection prevention
  • Sarcoma Diagnosis and Treatment
  • Soft tissue tumor case studies
  • Cancer and Skin Lesions
  • Global Cancer Incidence and Screening
  • Economic and Financial Impacts of Cancer
  • Pelvic and Acetabular Injuries
  • Head and Neck Cancer Studies
  • Electrospun Nanofibers in Biomedical Applications
  • Hemostasis and retained surgical items
  • History of Medical Practice
  • Lymphatic System and Diseases
  • Diagnosis and Treatment of Venous Diseases
  • Systemic Sclerosis and Related Diseases
  • Dental Education, Practice, Research
  • Hernia repair and management
  • Tumors and Oncological Cases
  • Estrogen and related hormone effects

CTO Hospital
2018-2025

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino
2016-2024

Presidio Ospedaliero
2023

Aziende Socio Sanitarie Territoriali di Lecco
2017

Associazione Italiana Di Oncologia Medica
2017

Azienda Ospedaliero Universitaria San Giovanni Battista
2012

University of Turin
2009

Negative pressure wound therapy was developed for treating wounds associated with unfavorable healing factors. The principles of the negative applied on clean and closed surgical incision originate (ciNPT). We evaluated use ciNPT in setting oncological breast surgery.From January 1, 2015, to June 31, we prospectively selected 37 patients undergoing surgery a minimum 4 risk Seventeen (25 surgeries) voluntary tested (ciNPT sample), whereas remaining 20 (22 chose conventional postsurgery...

10.1097/gox.0000000000001732 article EN cc-by-nc-nd Plastic & Reconstructive Surgery Global Open 2018-06-01

The role of forkhead-box A1 (FOXA1) and Androgen receptor (AR) in breast cancer (BC) has been extensively studied. However, the prognostic their co-expression Estrogen positive (ER+) BC not investigated so far. aim present study was thus to assess (protein mRNA) FOXA1 AR patients, order evaluate impact according ER status.Immunohistochemical expression evaluated on 479 consecutive BC, with complete clinical-pathological follow up data. Fresh-frozen tissues from 65 cases were available....

10.1186/s12885-018-4624-y article EN cc-by BMC Cancer 2018-07-03

Human Acellular Dermal Matrices (HADM) are employed in various reconstructive surgery procedures as scaffolds for autologous tissue regeneration. The aim of this project was to develop a new type HADM clinical use, composed glycerolized reticular dermis decellularized through incubation and tilting Dulbecco's Modified Eagle's Medium (DMEM). This manufacturing method compared with decellularization procedure already described the literature, based on use sodium hydroxide (NaOH), samples from...

10.1371/journal.pone.0149124 article EN cc-by PLoS ONE 2016-02-26

Background: Tubular carcinoma (TC) is a low proliferative grade 1 (G1) breast cancer (BC). Despite its favorable outcome and allegedly lower aggressiveness, patients are treated like other luminal G1 BC, with radiotherapy (RT) hormonal therapy (HT). We performed: (1) retrospective study comparing TC cohort control series of BC (2) systematic review meta-analysis focused on outcome. Materials Methods: selected 572 [111 TC, 350 not otherwise specified (NOS), 111 special-type (ST) BC] follow-up...

10.3389/fonc.2021.653388 article EN cc-by Frontiers in Oncology 2021-04-29

Background: Acellular dermal matrices (ADMs) entered the market in early 2000s and their use has increased thereafter. Several retrospective cohort studies single surgeon series reported benefits with of ADMs. However, robust evidence supporting these advantages is lacking. There need to define role for ADMs implant-based breast reconstruction (IBBR) after mastectomy. Methods: A panel world-renowned specialists was convened evaluate evidence, express personal viewpoints, establish...

10.1097/gox.0000000000004821 article EN cc-by-nc-nd Plastic & Reconstructive Surgery Global Open 2023-02-01

Oncological breast surgeries, classified as conserving surgery, oncoplastic and mastectomies (standard or with tissue sparing reconstruction), are burdened an overall complication rate up to 33%. Aquacel Ag Surgical is a combined hydrofiber-hydrocolloids dressing. The aim of this study evaluate the incidence surgical site complications in patients presenting three more risk factors (or two, which at least one "high risk"), undergoing cancer surgery with/without reconstruction, comparing...

10.1097/gox.0000000000003911 article EN cc-by-nc-nd Plastic & Reconstructive Surgery Global Open 2021-11-01
Coming Soon ...